Insufficient antibody validation challenges oestrogen receptor beta research

The discovery of oestrogen receptor β (ERβ/ESR2) was a landmark discovery. Its reported expression and homology with breast cancer pharmacological target ERα (ESR1) raised hopes for improved endocrine therapies. After 20 years of intense research, this has not materialized. We here perform a rigorous validation of 13 anti-ERβ antibodies, using well-characterized controls and a panel of validation methods. We conclude that only one antibody, the rarely used monoclonal PPZ0506, specifically targets ERβ in immunohistochemistry. Applying this antibody for protein expression profiling in 44 normal and 21 malignant human tissues, we detect ERβ protein in testis, ovary, lymphoid cells, granulosa cell tumours, and a subset of malignant melanoma and thyroid cancers. We do not find evidence of expression in normal or cancerous human breast. This expression pattern aligns well with RNA-seq data, but contradicts a multitude of studies. Our study highlights how inadequately validated antibodies can lead an exciting field astray.

[1]  C. Woolley,et al.  Multiple ERβ antisera label in ERβ knockout and null mouse tissues , 2010, Journal of Neuroscience Methods.

[2]  P. Argos,et al.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A , 1986, Nature.

[3]  J. Lehmann,et al.  Cloning and Characterization of Human Estrogen Receptor β Isoforms , 1998 .

[4]  M. Mottolese,et al.  A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study , 2008, Breast Cancer Research.

[5]  P. Jonsson,et al.  Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells. , 2013, Endocrine-related cancer.

[6]  Takuji Iwase,et al.  Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Hartman,et al.  Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. , 2009, Cancer research.

[8]  W. Miller,et al.  Molecular characterization of WDCP, a novel fusion partner for the anaplastic lymphoma tyrosine kinase ALK. , 2015, Biomedical reports.

[9]  V. Giguère,et al.  Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. , 1999, Molecular cell.

[10]  R. Laucirica,et al.  Estrogen receptor beta expression in invasive breast cancer. , 2001, Human pathology.

[11]  Minetta C. Liu,et al.  Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling , 2003, Oncogene.

[12]  H. Bonkhoff,et al.  Differential expression of the estrogen receptor beta (ERβ) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma , 2003, The Prostate.

[13]  Y. Homma,et al.  Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer , 2012, International journal of cancer.

[14]  Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells. , 2013, Endocrine-related cancer.

[15]  J. Lehmann,et al.  Cloning and characterization of human estrogen receptor beta isoforms. , 1998, Biochemical and biophysical research communications.

[16]  R. Tamimi,et al.  Estrogen receptor-β expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study , 2010, Modern Pathology.

[17]  H. Burger,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Estrogen Receptor Isoform Gene Expression in Ovarian , 2022 .

[18]  C. Reynolds,et al.  Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody , 2012, Journal of cellular biochemistry.

[19]  Richard A. Anderson,et al.  Differential Expression of Estrogen Receptor-α and -β and Androgen Receptor in the Ovaries of Marmosets and Humans , 2000 .

[20]  E. Jung,et al.  OCT-1 overexpression is associated with poor prognosis in patients with well-differentiated gastric cancer , 2014, Tumor Biology.

[21]  M. Baker.  Reproducibility crisis: Blame it on the antibodies , 2015, Nature.

[22]  J. Gustafsson,et al.  ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function , 2016, Oncotarget.

[23]  J. Gustafsson,et al.  Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells. , 2011, Molecular endocrinology.

[24]  I. Leav,et al.  ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. , 2010, Cancer cell.

[25]  Caroline Kampf,et al.  Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas , 2012, Journal of visualized experiments : JoVE.

[26]  Andreas Plückthun,et al.  Reproducibility: Standardize antibodies used in research , 2015, Nature.

[27]  P. Fuller,et al.  The importance of ERbeta signalling in the ovary. , 2010, The Journal of endocrinology.

[28]  J. Gustafsson,et al.  Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  G. Pelletier,et al.  Immunocytochemical Localization of Estrogen Receptors α and β in the Human Reproductive Organs , 2000 .

[30]  D. Neal,et al.  Estrogen receptor beta in prostate cancer: friend or foe? , 2014, Endocrine-related cancer.

[31]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Pelletier,et al.  Immunocytochemical localization of estrogen receptors alpha and beta in the human reproductive organs. , 2000, The Journal of clinical endocrinology and metabolism.

[33]  J. Gustafsson,et al.  ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway , 2014, Oncogene.

[34]  K. Jirström,et al.  High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy–Treated Patients—Results from a Population-Based Breast Cancer Cohort , 2016, Clinical Cancer Research.

[35]  P. Tarapore,et al.  Estrogen receptor-beta and breast cancer: Translating biology into clinical practice , 2012, Steroids.

[36]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[37]  J. Shine,et al.  Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.

[38]  C. Foster.  Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue , 2003 .

[39]  Chin-Yo Lin,et al.  Oestrogen receptors in breast cancer: basic mechanisms and clinical implications , 2013, Ecancermedicalscience.

[40]  L. Murphy,et al.  Assessment of multiple different estrogen receptor-β antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions , 2006, Breast Cancer Research and Treatment.

[41]  V. Speirs,et al.  Distinct expression patterns of ERα and ERβ in normal human mammary gland , 2002 .

[42]  F. Pontén,et al.  Analysis of Protein Expression in Cell Microarrays: A Tool for Antibody-based Proteomics , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[43]  J. Gustafsson,et al.  Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. , 2001, Cancer research.

[44]  F. Pontén,et al.  Estrogen receptor β expression induces changes in the microRNA pool in human colon cancer cells. , 2013, Carcinogenesis.

[45]  S. Krishnamurthy,et al.  ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR , 2012, Breast Cancer Research.

[46]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2016, Nucleic Acids Res..

[47]  B. Orr,et al.  Differential expression of estrogen receptor-alpha and -beta and androgen receptor in the ovaries of marmosets and humans. , 2000, Biology of reproduction.

[48]  L. Murphy,et al.  A bi-faceted role of estrogen receptor β in breast cancer. , 2013, Endocrine-related cancer.

[49]  K. Dahlman-Wright,et al.  Review Nuclear Receptor Signaling | The Open Access Journal of the Nuclear Receptor Signaling Atlas Estrogen receptor β: an overview and update , 2022 .

[50]  J. Gustafsson,et al.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  V. Speirs,et al.  Evaluation of seven oestrogen receptor β antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue , 2002, The Journal of pathology.

[52]  K. Korach,et al.  Estrogen receptor-beta is critical to granulosa cell differentiation and the ovulatory response to gonadotropins. , 2005, Endocrinology.

[53]  R. Schiff,et al.  Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters. , 2003, Cancer research.

[54]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[55]  J. Olson,et al.  ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer , 2014, BMC Cancer.

[56]  A. Shaaban,et al.  Re: Skliris et al. Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue. J Pathol 2002; 196: 155–162 , 2003, The Journal of pathology.

[57]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[58]  K. Dahlman-Wright,et al.  Estrogen receptor beta in breast cancer , 2014, Molecular and Cellular Endocrinology.

[59]  P. Chambon,et al.  Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. , 2000, Development.

[60]  Amber L. Couzens,et al.  The CRAPome: a Contaminant Repository for Affinity Purification Mass Spectrometry Data , 2013, Nature Methods.

[61]  Emma Lundberg,et al.  A proposal for validation of antibodies , 2016, Nature Methods.

[62]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[63]  V. Speirs,et al.  Distinct expression patterns of ER alpha and ER beta in normal human mammary gland. , 2002, Journal of clinical pathology.

[64]  J. Gustafsson,et al.  Estrogen Receptor β (ERβ) Level but Not Its ERβcx Variant Helps to Predict Tamoxifen Resistance in Breast Cancer , 2004, Clinical Cancer Research.

[65]  D. Chan,et al.  Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges , 2013, Clinical Proteomics.

[66]  A. Bookout,et al.  Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions. , 2010, Molecular endocrinology.

[67]  S. Fosså,et al.  Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score. , 2002, Human pathology.

[68]  R C Coombes,et al.  Estrogen receptor beta in breast cancer. , 2002, Endocrine-related cancer.

[69]  Mårtenn Sundberg,et al.  High-abundant protein depletion strategies applied on dog cerebrospinal fluid and evaluated by high-resolution mass spectrometry , 2015, Biochemistry and biophysics reports.

[70]  Margaret Warner,et al.  Estrogen receptors: how do they signal and what are their targets. , 2007, Physiological reviews.

[71]  E. Lundberg,et al.  Antibody performance in western blot applications is context-dependent. , 2014, Biotechnology Journal.

[72]  J. Gustafsson,et al.  ERβ Regulates NSCLC Phenotypes by Controlling Oncogenic RAS Signaling , 2014, Molecular Cancer Research.

[73]  Qiang Liu,et al.  Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis , 2016, Breast Cancer Research and Treatment.